SEC Comment Letter for KIWA BIO-TECH PRODUCTS GROUP CORP (CIK 0001159275) — Apr 2, 2020
KIWA BIO-TECH PRODUCTS GROUP CORP (CIK 0001159275)
Date: April 2, 2020 · CIK: 0001159275 · Accession: 0000000000-20-002843
AI Filing Summary & Sentiment
File numbers found in text: 000-33167
Letter
April 2, 2020 Wade Li Chief Executive Officer Kiwa Bio-Tech Products Group Corporation 3200 Guasti Road, Suite #100 Ontario, California 91761 Re:Kiwa Bio-Tech Products Group Corporation Preliminary Information Statement on Schedule 14C Filed March 18, 2020, as amended File No. 000-33167 Dear Mr. Li: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Robert L. B. Diener, Esq.
Show Raw Text
April 2, 2020
Wade Li
Chief Executive Officer
Kiwa Bio-Tech Products Group Corporation
3200 Guasti Road, Suite #100
Ontario, California 91761
Re:Kiwa Bio-Tech Products Group Corporation
Preliminary Information Statement on Schedule 14C
Filed March 18, 2020, as amended
File No. 000-33167
Dear Mr. Li:
We have completed our review of your filing. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Robert L. B. Diener, Esq.